Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Recurrent”

810 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 810 results

Testing effectiveness (Phase 2)Study completedNCT00005028
What this trial is testing

Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 46
Not applicableStudy completedNCT01833208
What this trial is testing

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Ended earlyNCT01200810
What this trial is testing

Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT00005848
What this trial is testing

R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center 7
Testing effectiveness (Phase 2)Ended earlyNCT01828476
What this trial is testing

Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 13
Large-scale testing (Phase 3)UnknownNCT00796458
What this trial is testing

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

Who this might be right for
PainProstate Cancer
A.O.U. San Giovanni Battista di Torino, Italy 200
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Large-scale testing (Phase 3)Study completedNCT02260817
What this trial is testing

Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Global Isotopes, LLC d/b/a Zevacor Molecular 109
Testing effectiveness (Phase 2)Ended earlyNCT01126879
What this trial is testing

Genistein in Treating Patients With Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more
Northwestern University 12
Early research (Phase 1)Ended earlyNCT04267939
What this trial is testing

ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

Who this might be right for
Advanced Solid Tumors (Excluding Prostate Cancer)Ovarian Cancer
Bayer 14
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Testing effectiveness (Phase 2)WithdrawnNCT00242931
What this trial is testing

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Not applicableNo Longer AvailableNCT05002465
What this trial is testing

Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Cancer Recurrent
Dana Mathews
Testing effectiveness (Phase 2)Looking for participantsNCT06617481
What this trial is testing

PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence

Who this might be right for
Prostate Cancer (Post Prostatectomy)
AdventHealth 30
Not applicableStudy completedNCT00303654
What this trial is testing

Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection

Who this might be right for
Bladder Cancer
Roei Medical Technologies Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT03899077
What this trial is testing

Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP

Who this might be right for
Cancer of Prostate
Cancer Research Antwerp 202
Testing effectiveness (Phase 2)Study completedNCT01576172
What this trial is testing

Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer AJCC v7
National Cancer Institute (NCI) 159
Early research (Phase 1)Study completedNCT00030277
What this trial is testing

High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Focus Surgery 20
Testing effectiveness (Phase 2)Study completedNCT00278070
What this trial is testing

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Who this might be right for
Breast CancerNon Small Cell Lung CancerProstate Cancer
Hellenic Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01882985
What this trial is testing

Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
University of California, Irvine 14
Load More Results